SCHEMBL4943060

SCHEMBL4943060

CS(=O)(=O)Cc1cc2ccccc2nn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.43
▸ GAA P10253 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ POLB P06746 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ GLA P06280 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ ACHE P22303 1/20 0.38
▸ MTOR P42345 1/20 0.36
▸ TLR8 Q9NR97 4/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ IKBKB O14920 1/20 0.33
▸ PIK3CB P42338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1273099 0.83 KDM4E (0.41) KDM4EGAALMNAALOX15TDP1
SCHEMBL1271353 0.83 KDM4E (0.40) KDM4EGAALMNAALDH1A1GLA
SCHEMBL3071109 0.77 ALDH1A1 (0.50) KDM4EGAALMNATDP1POLB
SCHEMBL9934343 0.76 KDM4E (0.46) KDM4EGAATDP1ALDH1A1GLA
SCHEMBL12737723 0.76 KDM4E (0.50) KDM4EGAATDP1ALDH1A1GLA
SCHEMBL3063629 0.75 KDM4E (0.48) KDM4EGAALMNATDP1POLB
SCHEMBL1272552 0.75 CYP1A2 (0.50) KDM4EGAALMNAALOX15TDP1
SCHEMBL4946548 0.74 CYP1A2 (0.46) GAALMNAALOX15TDP1POLB
SCHEMBL1273098 0.73 KDM4E (0.38) KDM4EGAAALDH1A1GLAMAPT
SCHEMBL8161366 0.72 KDM4E (0.46) KDM4EGAALMNATDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080287446-A1 Sulfonyl Containing Compounds as Cysteine Protease Inhibitors QUEST DIAGNOSTICS INVESTMENTS LLC 2008-11-20 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287446-A1 Sulfonyl Containing Compounds as Cysteine Protease Inhibitors CTSS, CTSF, CTSB KDM4E 2863/4885GAA 39/4885LMNA 2536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback